Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech
Mumbai (Maharashtra) [India], September 7: BSE-listed Sudarshan Pharma Industries Ltd [BSE Scrip Code: 543828, Trading Symbol: SUDARSHAN, ISIN: INE00TV01023] has announced its first major overseas biotech acquisition. In a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed exchanges that its Board of Directors atContinue Reading

